Biomed & Biotech Firms - Publicly Traded*

Fate Therapeutics Inc.

Company Website

3535 General Atomics Ct. Ste., 200
San Diego, CA 92121

Company Est.:

Year Est. in San Diego: n/a

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Fate Therapeutics Inc.

Market Cap as of 6/12/2015

$165,500,064

Market Cap as of 7/03/2014

Market Cap as of 07/02/2013

Market Cap as of 06/26/2012

Market Cap as of 01/04/2012

Market Cap as of 06/20/2011

Market Cap as of 01/06/2011

Exchange and Ticker Symbol

Fields of Research

Cellular therapeutics

Major Products

ProHema

Executives

Paul Grayson (profile)

  • Chief Executive Officer

Christian Weyer, M.D., M.A.S.

  • Chief Executive Officer
  • President